WW Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
WW International Inc. is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment. While there are some positive aspects, such as improving net income and EPS, the lack of strong trading signals, neutral sentiment from hedge funds and insiders, and declining revenue make it prudent to hold off on buying this stock at the moment. Additionally, the technical indicators and options data do not suggest a strong entry point.
The MACD histogram is positive at 0.467, indicating bullish momentum, but it is contracting, which suggests weakening strength. The RSI is neutral at 53.195, and moving averages are converging, showing no clear trend. Key resistance levels are at 24.541 and 26.264, while support levels are at 18.964 and 17.241. The stock is trading near resistance levels, which might limit immediate upside potential.
The partnership with PVOLVE to offer clinically validated workout methods and exclusive classes for members, particularly targeting midlife women and those on GLP-1 medications, could attract a niche audience. Improving net income and EPS in the latest quarter also indicate some operational improvements.
Revenue dropped by 10.78% YoY in Q3 2025, showing declining top-line performance. Additionally, competition in the GLP-1 drug market from Amazon and pharmaceutical giants like Eli Lilly and Novo Nordisk could pose challenges. Lack of significant insider or hedge fund activity suggests no strong confidence from key stakeholders.
In Q3 2025, revenue declined by 10.78% YoY to $172.09 million. However, net income improved by 24.52% YoY to -$57.52 million, and EPS surged by 893.10% YoY to -5.76. Gross margin increased by 4.33% YoY to 72.11%. While profitability metrics are improving, the revenue decline is a concern.
No recent analyst rating or price target changes are available for WW International Inc.
